Condition: Intracranial Arteriosclerosis · Stenosis Artery · Drug-Eluting Stents · Sponsor: Sino Medical Sciences Technology Inc.
The primary objective of this trial is to evaluate the long-term safety and efficacy of the NOVA intracranial drug-eluting stent system in "real world" patients with intracranial atherosclerotic stenosis.
This description comes directly from the study's public registry record.
Zhongrong Miao, MD · +8613601243293 · zhongrongm@163.com
Baixue Jia, MD
Always discuss trial participation with your own doctor first.
| First People's Hospital of Chenzhou | Chenzhou, China | Recruiting |
| Ganzhou People's Hospital | Ganzhou, China | Recruiting |
| Jinhua Municipal Central Hospital | Jinhua, China | Recruiting |
| The First Affiliated Hospital of Ningbo University | Ningbo, China | Recruiting |
| Shanxi Cardiovascular Hospital | Shanxi, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05692882